Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not.

Zwart, W H; Dijkstra, E A; Putter, H; Marijnen, C A M; Nilsson, P J; van de Velde, C J H; van Etten, B; Hospers, G A P; Glimelius, B

Zwart, W H; Dijkstra, E A; Putter, H; Marijnen, C A M; Nilsson, P J; van de Velde, C J H; van Etten, B; Hospers, G A P; Glimelius, B.

Afiliación

Zwart WH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: w.h.zwart@umcg.nl.
Dijkstra EA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Putter H; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands.
Marijnen CAM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiation Oncology, Leiden University Medical Center, Leiden, the Netherlands.
Nilsson PJ; Department of Surgery, Karolinska University Hospital, Stockholm, Sweden.
van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands.
van Etten B; Department of Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Hospers GAP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Glimelius B; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

ESMO Open ; 8(5): 101645, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37713932

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ESMO Open Año: 2023 Tipo del documento: Article